Zdrowie i gospodarka · 10/11/1998
FDA Releases Draft Guidance for Biological In Vitro Diagnostic Products
The FDA has released a draft guidance document to help companies prepare the necessary information for biologics license applications for biological in vitro diagnostic products, aiming to reduce industry burdens while maintaining public health protection.